Why the study?
Does the Magenta Elevate pump provide safe and effective mechanical circulatory support in patients undergoing high-risk PCI?
Observational (n=14)
No
Does the Magenta Elevate pump provide safe and effective mechanical circulatory support in patients undergoing high-risk PCI?
Answers are grounded in this paper and cite their sources.
The novel Magenta Elevate percutaneous ventricular assist device demonstrated a promising initial safety and efficacy profile in a first-in-human study of patients undergoing high-risk PCI.
The Magenta Elevate (Magenta Medical Ltd.) pump-a novel transvalvular percutaneous ventricular assist device-was tested in the first-in-human study at the Israeli-Georgian Medical Research Clinic 'Helsicore' in Tbilisi, Georgia. Results on 14 patients undergoing high-risk percutaneous coronary intervention suggested a promising safety and efficacy profile. Characterized by a low profile, percutaneous insertion, and a self-expandable pump, the Magenta Elevate pump holds promising venues for the implementation of mechanical circulatory support in a wide range of patients.
No takes yet. Share an insight, caveat, or question.
Ursoleo et al. (2025) conducted an observational in High-risk percutaneous coronary intervention (n=14). Magenta Elevate pump was evaluated on Safety and efficacy profile.
Synapse has enriched 10 related papers. Consider them for comparative context: